keyword
https://read.qxmd.com/read/38588822/low-dose-oral-minoxidil-improves-hair-length-and-global-hair-density-in-short-anagen-syndrome
#21
JOURNAL ARTICLE
Anthony Moussa, Emadodin Darchini-Maragheh, Dmitri Wall, Nekma Meah, Rodney Sinclair
No abstract text is available yet for this article.
April 6, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38587306/intense-pulsed-light-ipl-for-the%C3%A2-treatment-of-vascular-and-pigmented-lesions
#22
JOURNAL ARTICLE
Avdulaj Arminda
BACKGROUND: IPL devices emit a wide range of wavelengths that can be absorbed by different chromophores in the skin. Selective destruction of a specific chromophore with minimal side effects is controlled by wavelength, pulse duration, and fluence. AIM: This study aims to evaluate the treatment of vascular and pigmented lesions using narrow-band Intense Pulsed Light (IPL) with Advanced Fluorescence Technology (AFT), which offers more efficient energy usage per pulse to increase safety, and improve clinical outcomes...
April 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38584311/effectiveness-of-risankizumab-for-the-treatment-of-psoriatic-arthritis-a-multicenter-real-world-study
#23
JOURNAL ARTICLE
Dario Graceffa, Arianna Zangrilli, Giacomo Caldarola, Viviana Lora, Diego Orsini, Gala Moretta, Gianluca Pagnanelli, Alessia Provini, Cinzia Masini, Mauro Bavetta, Domenico Giordano, Antonio Richetta, Ersilla Tolino, Luca Bianchi, Ketty Peris, Francesca Sperati, Claudio Bonifati
BACKGROUND: IL-23 inhibitors were recently approved for the treatment of skin psoriasis and psoriatic arthritis (PsA). Risankizumab, a humanized monoclonal antibody that specifically binds the p19 subunit of IL-23, has proven effective on PsA in two randomized controlled trials. To date, only a few real-world data are available on this topic. METHODS: Our study aimed to prospectively evaluate the effectiveness of risankizumab in patients with PsA in a real-world setting...
April 7, 2024: International Journal of Dermatology
https://read.qxmd.com/read/38576950/congenital-single-kidney-in-tuberous-sclerosis-complex-bourneville-disease
#24
Wafaa Bzeih, Mohammad Kbar, Oussama Rihan
INTRODUCTION: Bournevile disease is a rare global condition that presents a diagnostic challenge due to its diverse multisystemic involvement. CASE PRESENTATION: This report presents the case of a 14-year-old male with a medical history of congenital single kidney, heart rate abnormalities, Bournevile disease with cognitive deficits, brain lesions, and dermatological features. The patient presented with sudden onset renal angiolipomatosis, and the diagnosis was based on specific computed tomography (CT) findings...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38576696/comparing-the-efficacy-of-topical-4-benzoyl-peroxide-versus-topical-0-1-adapalene-for-treatment-of-acne-vulgaris-in-skin-of-color-population-a-south-asian-perspective
#25
JOURNAL ARTICLE
Asmat Ullah, Anjum Muhammad, Farman Mehmood, Hina Farooq, Bilal Ahmad, Afnan Bin Haq, Naseem Khan, Syeda Naz, Asghar Khan, Afshan Saeed
Introduction Acne vulgaris is one of the most common skin problems encountered in the dermatology department. It is a chronic, inflammatory disease of the pilosebaceous unit, clinically presenting with comedones, papules, pustules, nodules, and cysts. With its particularly high prevalence in the younger population, it has significant adverse sequelae on patient's quality of life. At present, due to an enhanced understanding of the pathogenesis of acne, various therapeutic modalities are available. The current management strategies generally follow a systematic treatment escalation based on disease severity and treatment response...
March 2024: Curēus
https://read.qxmd.com/read/38576246/facial-dermatoses-associated-with-mask-wearing-in-the-covid-19-era-a-nationwide-cross-sectional-multicenter-questionnaire-based-study
#26
JOURNAL ARTICLE
Myoung Eun Choi, Woo Jin Lee, Joo Yeon Ko, Kwang Joong Kim, Jung Eun Kim, Hei Sung Kim, Kui Young Park, Mi Youn Park, Dae Hun Suh, Kihyuk Shin, Min Kyung Shin, Hyo Hyun Ahn, Weon Ju Lee, Jee Bum Lee, Hee Jung Lee, Min Soo Jang, Seung Hyun Cheong, Soyun Cho, Yu Sung Choi, You Won Choi, Hoon Choi, Mi Woo Lee
BACKGROUND: Daily usage of facial masks during coronavirus disease 2019 pandemic influenced on facial dermatoses. OBJECTIVE: This study investigated the impact of mask-wearing habits on facial dermatoses. METHODS: A nationwide, observational, questionnaire-based survey was conducted from July through August 2021, involving 20 hospitals in Korea. RESULTS: Among 1,958 facial dermatoses, 75.9% of patients experienced aggravation or development of new-onset facial dermatoses after wearing masks...
April 2024: Annals of Dermatology
https://read.qxmd.com/read/38576244/a-comprehensive-review-of-the-acne-grading-scale-in-2023
#27
REVIEW
In Ho Bae, Jun Ho Kwak, Chan Ho Na, Min Sung Kim, Bong Seok Shin, Hoon Choi
Acne is a common skin inflammatory condition that can significantly affect the patient's quality of life. Therefore, accurate assessment scales are very important for treatment and management of acne vulgaris. This review article issues a comprehensive review of various acne severity assessment scales. In this text, the authors review the acne grading scales, such as the Pillsbury scale, Cook's acne grading scale, Leeds acne grading system, Global Acne Grading System, and investigator's global assessment, etc...
April 2024: Annals of Dermatology
https://read.qxmd.com/read/38574764/clinico-mycological-and-therapeutic-updates-on-tinea-corporis-cruris-in-the-era-of-trichophyton-indotineae
#28
REVIEW
A Khurana, S Savitha, K Sardana, A Chowdhary
Trichophyton indotineae (TI) has emerged as a novel dermatophyte species causing treatment recalcitrant skin infections. While the earliest reports came from India, TI has now spread to many parts of the world and is rapidly becoming a global health concern. Accurate identification of TI requires elaborate mycological investigations not in the domain of routine microbiology laboratories. Extensive, non-inflammatory and atypical presentations are commonly seen with this novel species. TI shows an alarmingly high rate of mutations in the squalene epoxidase gene leading to lowered invitro susceptibility to terbinafine...
April 2, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38572773/management-of-moderate-to-severe-psoriasis-with-brodalumab-real-world-evidence-from-the-libero-study
#29
JOURNAL ARTICLE
R von Kiedrowski, T Hinz, G Mauer, A Schwinn, A Timmel, H J Hutt, M Augustin
BACKGROUND: Brodalumab, a fully human monoclonal immunoglobulin IgG2 antibody that binds the human interleukin 17 receptor subunit A, is available for the treatment of moderate-to-severe plaque psoriasis in Europe since September 2017, but so far there are only a few studies on its use in real-world conditions. OBJECTIVES: To assess the management of moderate-to-severe psoriasis with brodalumab 210 mg in daily practice after 12 and 52 weeks (W). In addition, patient profiles and treatment pathways are described...
April 4, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38572527/open-clinical-trial-evaluating-the-efficacy-of-a-novel-eyelash-growth-enhancer-with-peptides-and-glycosaminoglycans
#30
JOURNAL ARTICLE
Pablo Fernandez-Gonzalez, Maria Teresa Truchuelo-Díez, Maria José Gómez-Sánchez
BACKGROUND: Eyelashes play a crucial role in self-image and ocular protection. Enhancements to their structure are of both cosmetic and clinical interest. AIMS: To assess the efficacy of a peptide and glycosaminoglycan-based eyelash enhancer serum in improving eyelash structure. PATIENTS/METHODS: This open-label clinical trial involved 30 females aged 25-65. Eyelashes were assessed at baseline (D0), 4 weeks (D28), and 12 weeks (D84) using specialized software and high-resolution imagery...
April 4, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38572054/global-scientific-overview-of-dermatology-related-to-covid-19-a-bibliometric-analysis
#31
JOURNAL ARTICLE
Miguel Cabanillas-Lazo, Carlos Quispe-Vicuña, Claudia Cruzalegui-Bazán, Juan C Valencia-Martinez, Josmel Pacheco-Mendoza, Frank Mayta-Tovalino
BACKGROUND: Coronavirus disease 2019 (COVID-19) has had a significant impact on dermatology, but to date no bibliometric analysis of this field has been identified. Therefore, the aim of this study was to perform a bibliometric indicator analysis of the worldwide scientific production of COVID-19 in dermatology. MATERIALS AND METHODS: An advanced bibliographic search was performed in the Scopus database to identify articles on COVID-19 and dermatology from 2020 to 2021...
2024: Indian Journal of Dermatology
https://read.qxmd.com/read/38569598/a-systematic-review-investigating-the-proportion-of-clinical-images-shared-in-prospective-randomized-controlled-trials-involving-patients-with-atopic-dermatitis-and-systemic-pharmacotherapy
#32
REVIEW
Sam Polesie, Mikael Alsterholm
For individuals with atopic dermatitis (AD), interpreting scientific papers that present clinical outcomes including the Eczema Area and Severity Index (EASI) and Investigators Global Assessment may be difficult. When compared to tabulated data and graphs, images from before and after treatment are often far more meaningful to these patients that ultimately will be candidates for the treatment. This systematic review focused on determining the frequency of clinical image sharing in AD research. Conducted in accordance with PRISMA guidelines, the review concentrated on randomized controlled trials that investigated predefined and available systemic treatments for AD...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38564400/a-practical-algorithm-integrating-skin-care-with-nonenergy-and-injectable-dermatologic-procedures-to-improve-patient-outcomes-and-satisfaction
#33
JOURNAL ARTICLE
Edward Lain, Anneke Andriessen, Valeria Barreto Campos, Sabrina Guillen Fabi, Lisa Ginn, Ariel Haus, Valerie M Harvey, Jean-François Tremblay
BACKGROUND: The most rapidly increasing medical aesthetic procedures for facial antiaging comprise nonenergy and injectable treatments. Currently, standards for skin care before, during, and after nonenergy and injectable treatments are lacking. The algorithm on supportive skin care for facial antiaging nonenergy and injectable treatments aims to stimulate healing, reduce downtime, and improve comfort and treatment outcomes.  Methods: A panel of 7 global physicians employed a modified Delphi method and reached a consensus on an algorithm for supportive skin care for nonenergy and injectable antiaging treatments based on the best available evidence and the panel members’ clinical experiences and opinions...
April 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38564399/treatments-for-moderate-to-severe-acne-vulgaris-a-systematic-review-and-network-meta-analysis
#34
JOURNAL ARTICLE
Julie C Harper, Hilary Baldwin, Saswata Paul Choudhury, Deepti Rai, Bikramaditya Ghosh, Md Sohai Aman, Abhra R Choudhury, Sekhar Kumar Dutta, Debalina Dey, Subrata Bhattacharyya, Tina Lin, George Joseph, Ankur A Dashputre, Jerry K L Tan
BACKGROUND: Multiple treatment options exist for the management of moderate-to-severe acne. However, the comparative effectiveness (efficacy/safety) of moderate-to-severe acne treatments has not been systematically examined. METHODS: A systematic literature review (SLR) was conducted to identify randomized controlled trials of ≥4 weeks of treatment (topical, oral, physical, or combinations) for moderate-to-severe facial acne in patients aged ≥9 years...
April 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38564392/effectiveness-and-safety-of-a-new-hyaluronic-acid-injectable-for-augmentation-and-correction-of-chin-retrusion
#35
RANDOMIZED CONTROLLED TRIAL
Andreas Nikolis, Shannon Humphrey, Jason K Rivers, Vince Bertucci, Nowell Solish, William McGillivray, Kristy Bailey, Nathan Rosen, Andrei Metelitsa, Annika Rugheimer, Felipe Weinberg, Inna Prygova, Torun Bromee
BACKGROUND: A hyaluronic acid (HA) filler intended for non-surgical improvement of chin appearance should ideally be of high strength/firmness (high G') to allow for deep injections on the bone. HASHA (Restylane Shaype) is a new hyaluronic acid (HA) injectable with high G' and high HA concentration (25 mg/mL), engineered by the new NASHA-HD (High Definition) technology. HASHA is suitable to be placed periosteally, aiming to mimic the natural shape of the bony chin. This pivotal clinical investigation evaluated effectiveness and safety of HASHA for augmentation and correction of chin retrusion...
April 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38562369/knowledge-and-attitudes-towards-topical-corticosteroids-among-previous-users-in-the-general-population-of-saudi-arabia
#36
JOURNAL ARTICLE
Raham A Alamri, Hanadi S Al Satti
Introduction Topical corticosteroids are a valuable tool for treating many dermatoses, offering anti-inflammatory and immunosuppressive properties. However, preexisting knowledge gaps and safety concerns may hinder treatment compliance. This study aims to evaluate knowledge and attitudes towards topical corticosteroids among former users within the general population of Saudi Arabia. Methods This cross-sectional study utilized an online survey to collect data. Knowledge was assessed through three dimensions: indications, proper use, and adverse reactions...
March 2024: Curēus
https://read.qxmd.com/read/38558692/smart-watches-lack-skin-smarts-current-and-future-dermatologic-applications-in-device-metrics
#37
JOURNAL ARTICLE
Troy A Black, Mariya George, Morgan A Rousseau, Rashid M Rashid
Smartwatches have proven life-saving in medical specialties such as cardiology. Smartwatches actively warn us of arrhythmia risk and loud noise exposure. However, dermatologic health metrics are rarely monitored, and users are never alerted of potential skin health issues. Furthermore, the role of these devices within dermatology has not been evaluated in the literature. This study aims to analyze the current data points monitored by smartwatches and discuss potential adaptations to support dermatologic patient education and improve clinical management...
February 2024: Curēus
https://read.qxmd.com/read/38558626/eczema-herpeticum-complicating-atopic-dermatitis-a-rare-presentation
#38
Mariana Pedro, Marta Caldas, Fernanda Neves, Sara Diogo, Fabiana Fortunato
Atopic dermatitis (AD) has become a global health concern due to an increase in its frequency over the past few decades. This illness not only reduces the quality of life but also imposes a considerable financial burden due to the increased risk of skin infections. This case report explores the presentation of a four-month-old male infant with a personal history of atopic dermatitis that developed yellow scaly lesions on the scalp, which were assumed to be cradle cap. However, there was a clinical worsening of the cutaneous lesions, with the appearance of vesicles, so he was referred to the Pediatric Emergency Room after an urgent dermatology appointment...
February 2024: Curēus
https://read.qxmd.com/read/38556870/very-low-calorie-ketogenic-diet-vlckd-a-therapeutic-nutritional-tool-for-acne
#39
JOURNAL ARTICLE
Ludovica Verde, Evelyn Frias-Toral, Sara Cacciapuoti, Daniel Simancas-Racines, Matteo Megna, Giuseppina Caiazzo, Luca Potestio, Maria Maisto, Gian Carlo Tenore, Annamaria Colao, Silvia Savastano, Giovanna Muscogiuri, Luigi Barrea
BACKGROUND: Acne, a chronic inflammatory disease impacting the pilosebaceous unit, is influenced significantly by inflammation and oxidative stress, and is commonly associated with obesity. Similarly, obesity is also associated with increased inflammation and oxidation. The role of diet in acne remains inconclusive, but the very low-calorie ketogenic diet (VLCKD), known for weight loss and generating anti-inflammatory ketone bodies, presents promising potential. Despite this, the effects of VLCKD on acne remain underexplored...
March 31, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38556093/long-term-safety-and-effectiveness-of-roflumilast-cream-0-3-in-adults-with-chronic-plaque-psoriasis-a-52-week-phase-2-open-label-trial
#40
JOURNAL ARTICLE
Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris, Melinda J Gooderham, H Chih-Ho Hong, Steven E Kempers, Leon H Kircik, Mark Lebwohl, Wei Jing Loo, Walter K Nahm, Kim A Papp, Daniel Stewart, Darryl P Toth, Matthew Zirwas, David Krupa, Scott Snyder, Patrick Burnett, Robert Higham, David R Berk
BACKGROUND: Efficacy and/or safety profiles limit topical psoriasis treatments. OBJECTIVE: Evaluate long-term effects of once-daily roflumilast cream 0.3% in patients with psoriasis. METHODS: In this open-label phase 2 trial, adult patients (N = 332) with psoriasis who completed the phase 2b parent trial or were newly enrolled applied roflumilast once-daily for 52 weeks. Safety and effectiveness were assessed. RESULTS: Overall, 244 patients (73...
March 29, 2024: Journal of the American Academy of Dermatology
keyword
keyword
87724
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.